Drug recalls from US raise export concerns

THE RECENT DRUG recalls by US arms of Indian drugmakers have turned the spotlight back on quality issues faced by the domestic pharma companies in the lucrative export market.

- MANU KAUSHIK

Currently, Aurobindo Pharma, Glenmark and Zydus are in the process of recalling their products in the US market due to manufacturing issues. While the concerns around Aurobindo Pharma and Glenmark Pharma pertain to the "deviation from the current good manufacturing practices (cGMP)", in the case of Zydus, wrong labelling is the reason for recall. Experts said the recent instances of recall could impact the Indian pharma industry which is already facing the heat globally due to a spate of quality issues over the past two years.